在癌症中,SMARCA4/2损失会减少BCL-xL的表达,并赋予癌症中可用药的MCL1依赖性
Jialin Jiang1,2, Xianbing Zhu1,2, Zheng Fu1,2
1Department of Biochemistry, McGill University, Montreal, QC, Canada.
NPJ precision oncology
|March 11, 2026
概括
在侵袭性癌症中,SMARCA4/2的丧失会导致对MCL1.2的依赖. 抑制MCL1可以选择性地杀死这些癌细胞,为SMARCA4/2-缺乏SCCOHT和NSCLC提供潜在的新疗法.
科学领域:
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
- 染色体重塑 染色体重塑 的方法
背景情况:
- SMARCA4 (BRG1) 和SMARCA2 (BRM) 是SWI/SNF染色体重塑剂的关键子单元,在癌症中经常发生变化.
- 在SCCOHT和NSCLC等侵袭性癌症中,SMARCA4和SMARCA2的损失发生,与糟糕的结果和化学抵抗有关.
研究的目的:
- 为了确定与癌症中SMARCA4/2损失相关的治疗漏洞.
- 为了研究SMARCA4/2-缺乏癌细胞中的合成致命相互作用.
主要方法:
- 功能性遗传查,以确定SMARCA4/2-缺陷细胞中的依赖性.
- 使用RNA干扰 (RNAi) 和小分子抑制剂 (S63845) 向MCL1.1.
- 在临床前模型中评估亡诱导和瘤生长抑制.
主要成果:
- 在SMARCA4/2-缺乏SCCOHT和NSCLC细胞中通过RNAi或S63845选择性诱导的亡来抑制MCL1.
- 损失SMARCA4/2导致BCL-xL表达的减少,从而使其对MCL1的生存产生依赖.
- S63845治疗显著抑制了SMARCA4/2-缺陷癌症患者衍生异种移植的瘤生长.
结论:
- 在SMARCA4/2损失的癌症中,MCL1是一种合成致命标.
- 向MCL1代表了SMARCA4/2-缺乏SCCOHT和NSCLC的有前途的治疗策略.
相关概念视频
The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
The Retinoblastoma Gene
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K


